Fig. 1.
Leukocyte counts (109/L) and peripheral blood blast levels (%) during the first 8 weeks of treatment with imatinib in patients with a confirmed diagnosis and available values for WBC (blasts).
Values were 213 (199) on day 7, 207 (194) on day 14, 196 (181) on day 28, 173 (156) on day 42, and 160 (147) on day 56. Values are median values, with vertical lines extending to 25th and 75th percentiles.
